Content by University of North Carolina Lineberger Comprehensive Cancer Center
Researchers suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, the most common type of kidney cancer
| 3 min read
Findings could give insight into cancer and other diseases that affect the physical properties of the nucleus
| 2 min read
Page 1 of 1 - 2 Total Items